Liu, Z., Qin, W., Peng, T. (2025). Efficacy and safety of transarterial therapy combined with donafenib plus programmed cell death protein-1 inhibitors for unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16210